KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.63 $3.18 Friday, 26th Apr 2024 GLYC stock ended at $1.64. This is 4.09% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.30% from a day low at $1.63 to a day high of $1.76.
90 days $1.63 $3.50
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Oct 26, 2023 $1.15 $1.26 $1.14 $1.25 130 933
Oct 25, 2023 $1.15 $1.20 $1.11 $1.13 157 057
Oct 24, 2023 $1.15 $1.22 $1.15 $1.15 151 844
Oct 23, 2023 $1.26 $1.27 $1.12 $1.17 370 928
Oct 20, 2023 $1.29 $1.32 $1.25 $1.26 120 494
Oct 19, 2023 $1.32 $1.33 $1.29 $1.30 34 386
Oct 18, 2023 $1.41 $1.43 $1.31 $1.31 127 404
Oct 17, 2023 $1.44 $1.45 $1.41 $1.41 95 302
Oct 16, 2023 $1.41 $1.45 $1.40 $1.43 221 936
Oct 13, 2023 $1.25 $1.42 $1.24 $1.42 355 590
Oct 12, 2023 $1.28 $1.29 $1.22 $1.25 135 660
Oct 11, 2023 $1.32 $1.37 $1.28 $1.28 118 661
Oct 10, 2023 $1.34 $1.34 $1.32 $1.32 79 610
Oct 09, 2023 $1.38 $1.39 $1.33 $1.35 94 951
Oct 06, 2023 $1.41 $1.49 $1.39 $1.39 149 292
Oct 05, 2023 $1.40 $1.50 $1.40 $1.43 55 596
Oct 04, 2023 $1.42 $1.48 $1.39 $1.39 50 726
Oct 03, 2023 $1.40 $1.48 $1.38 $1.42 113 594
Oct 02, 2023 $1.50 $1.50 $1.36 $1.42 197 123
Sep 29, 2023 $1.56 $1.57 $1.46 $1.50 120 700
Sep 28, 2023 $1.46 $1.58 $1.46 $1.57 122 853
Sep 27, 2023 $1.48 $1.54 $1.45 $1.48 188 580
Sep 26, 2023 $1.31 $1.48 $1.31 $1.43 213 894
Sep 25, 2023 $1.39 $1.39 $1.28 $1.29 149 689
Sep 22, 2023 $1.36 $1.41 $1.30 $1.41 229 963
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT